Skip to main content

Causes, Risk Factors, and Prevention of Childhood Leukemia

The exact cause of most childhood leukemias is not known. Scientists have found some genetic and environmental risk factors, but most children with leukemia do not have any known risk factors. A risk factor is anything that affects a person’s chance of getting a disease such as cancer.

What causes childhood leukemia?

Lifestyle-related risk factors for adult cancers like tobacco use, alcohol use, diet, exercise, and having excess weight are not known to play a major role in childhood cancers. Most children with leukemia have no known risk factors, so it is important to know that there is nothing these children or their parents could have done to prevent these cancers.

While the exact cause of many leukemias is unknown, certain gene changes in normal bone marrow cells can cause them to multiply out of control and become leukemia cells. Certain environmental factors can also increase the risk of childhood leukemia.

Researchers continue to search for answers about why leukemia happens in children.

Genetic risk factors

Genetic risk factors are those that are part of our DNA (the substance that makes up our genes), which controls how our bodies function. Only a small number of children inherit DNA changes from a parent that increases their risk of cancer. Most gene changes that cause childhood leukemia are acquired mutations that occur early, sometimes before birth.

In rare cases, exposure to radiation and certain chemicals is known to increase the risk of cancer. However, not everyone exposed to these things will develop cancer. This is because each of us has unique genes that control how our bodies react to these types of exposures. Some people have different versions of these genes, called gene variants, that make them less effective. Children who inherit one of these gene variants may not be able to break down harmful chemicals well after exposure or repair damage to DNA from radiation. This can lead to a higher risk of developing leukemia over time.

Genetic syndromes

Some genetic disorders increase a child’s risk of developing several types of leukemia:

Children with Down syndrome have an extra (third) copy of chromosome 21. They are more likely to develop either acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) than other children, with an overall risk of about 2% to 3%. Down syndrome has also been linked with transient leukemia (also known as transient myeloproliferative disorder [TMD or TAM]), a leukemia-like condition within the first month of life, which may resolve on its own with no or very little treatment.

Li-Fraumeni syndrome is a rare condition caused by a change in the TP53 gene. People with this change have a higher risk of developing several kinds of cancer, including leukemia, bone or soft tissue sarcomas, breast cancer, adrenal gland cancer, and brain tumors.

NF1 is a cancer syndrome caused by a change in the NF1 gene that causes tumors to grow on the skin, nerves, and bones. It increases the risk of developing several types of cancer, including leukemias.

When the bone marrow fails, the bone marrow is unable to make enough healthy blood cells and blood counts are low. The failing bone marrow can create cells with DNA that is fragile, has mutations, or is unprotected, leading to damage. This increases the risk of many types of cancer. Some examples of these bone marrow failure syndromes are Fanconi Anemia (FA), Dyskeratosis congenita (DKC), and Shwachman-Diamond Syndrome (SDS).

In these conditions, the immune system does not work properly. This can lead to infections and the growth and division of damaged cells, causing cancers like leukemia. These conditions include Ataxia-telangiectasia (AT) and Bloom syndrome.

Noonan syndrome is a genetic condition that has been associated with JMML.

Having a sibling with leukemia

Siblings of children with acute leukemia have a slightly increased chance of developing leukemia, but the overall risk is still low.

The risk for acute leukemias is much higher among twins. For AML and ALL that is diagnosed before one year of age, both identical twins almost always develop leukemia. If leukemia develops after one year of age or the twins are not identical, the risk for developing leukemia in the other twin is less, but still more than average.

Chronic leukemias do not seem to run in families. Having a parent who develops leukemia as an adult does not seem to raise a child’s risk of leukemia either.

Environmental risk factors

Environmental risk factors are things in our surroundings that increase the risk of getting leukemia, such as radiation, chemicals, and infections.

Exposure to high levels of radiation is a risk factor for childhood acute leukemias. It is also the only known environmental risk factor for CML. Japanese atomic bomb survivors had a high risk of developing leukemias. If a baby is exposed to radiation before birth, there may also be an increased risk of childhood leukemia, but the extent of the risk is not clear.

The possible risks from fetal or childhood exposure to lower levels of radiation, like radiation from x-rays or CT scans, are not known. Some studies have found a slight increase in risk, while others have found no increased risk. Any risk increase is likely to be small. However, to be safe, most doctors recommend that pregnant women and children do not get these tests unless they are needed.

Children and adults treated for other cancers with certain chemotherapy drugs have a higher risk of getting a second cancer, such as AML, later in life. Drugs like cyclophosphamide, doxorubicin, etoposide, and teniposide have been linked to a higher risk of leukemia. These leukemias usually develop within 10 years of treatment, and they tend to be harder to treat.

Exposure to chemicals such as benzene (a solvent used in the cleaning industry and to manufacture some drugs, plastics, and dyes) may cause acute leukemia in adults and, rarely, in children. Exposure to perfluoroalkyl substances (PFAS) found in common household items like non-stick cookware and exposure to higher amounts of air pollution in early life have also been associated with childhood leukemias.

Several studies have found a possible link between childhood leukemia, specifically AML, and household exposure to pesticides either before birth or in early childhood. Some studies have also found parental exposure to paint and solvents to be associated with a higher risk of pediatric AML.

Studies of environmental exposures can be difficult to do. More research is needed to confirm these findings and provide more specific information about the possible risks.

Viral infections have been linked to some types of childhood cancers.

The immune system plays a crucial role in fighting infections and removing injured or damaged cells. In some cases, researchers think that some childhood leukemias may result from an abnormal immune system response to an infection.

One theory suggests that childhood leukemia may develop more commonly in children exposed to certain germs (particularly viruses) later than normal. This “delayed infection” (after the first year of life) might affect the immune system in a way that allows abnormal cells to escape the system. This might help explain why some studies have found that the risk of childhood leukemia seems to be lower in children who were in daycare during their first year of life, which would have exposed them to common infections earlier.

Other researchers suggest that the movement of people around the world is resulting in exposure to new germs. Research suggests this may trigger an abnormal immune response which leads to leukemia development.

Children who are getting intensive treatment to suppress their immune system (mainly children who have had organ transplants) have an increased risk of certain cancers, such as lymphoma and ALL.

Doctors are looking for ways to treat people without raising the risk of leukemia. For now, the benefits of treating life-threatening diseases with organ transplants must be balanced against the small chance of developing leukemia several years later.

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

Aplenc R, Elgarten CW, Choi JK, Meshinchi S. Chapter 17A: Acute Myeloid Leukemia and Myelodysplastic Syndromes. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Pediatric Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2021.

Gramatges MM, O’Brien MM, Rabin KR. Chapter 16: Acute Lymphoblastic Leukemia. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Pediatric Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2021.

Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193-203.

Jones RR, Madrigal JM, Troisi R, et al. Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 2024;116(5):728-736.

National Cancer Institute. Childhood Acute Lymphoblastic Leukemia Treatment (PDQ). 2025. Accessed at https://www.cancer.gov/types/leukemia/hp/child-all-treatment-pdq on May 7, 2025.

National Cancer Institute. Childhood Acute Myeloid Leukemia Treatment (PDQ). 2025. Accessed at https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq on May 7, 2025.

Seif AE. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet. 2011;204(5):227-244.

Williams LA, Haynes D, Sample JM, et al. PM2.5, vegetation density, and childhood cancer: a case-control registry-based study from Texas 1995-2011. J Natl Cancer Inst. 2024;116(6):876-884. 

Last Revised: July 22, 2025

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.